Activation of T cells by carbamazepine and carbamazepine metabolites. - Wikidata - wikimedia - TriplyDB

Activation of T cells by carbamazepine and carbamazepine metabolites.

Activation of T cells by carbamazepine and carbamazepine metabolites.

http://www.wikidata.org/entity/Q34543711

about

Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury Idiosyncratic adverse drug reactions: current concepts Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.Metabolism considerations for kinase inhibitors in cancer treatment In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers Immunological principles of T-cell-mediated adverse drug reactions in skin.Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.Delayed drug hypersensitivity: models of T-cell stimulation Delayed drug hypersensitivity reactions - new concepts.Immune mediation of hypersensitivity adverse drug reactions: implications for therapy.In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.Pharmacogenetics of toxic epidermal necrolysis.Skin manifestations of drug allergy.Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions.Investigative safety science as a competitive advantage for Pharma.Anticonvulsant hypersensitivity syndrome: an update.T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.HLA and pharmacogenetics of drug hypersensitivity.The generation, detection, and effects of reactive drug metabolites.Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?Stevens-johnson syndrome induced by carbamazepine treatment in a patient who previously had carbamazepine induced pruritus - a case report -.Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen.Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.Avidity determines T-cell reactivity in abacavir hypersensitivity.Stevens-Johnson syndrome induced by the cross-reactivity between teicoplanin and vancomycin.Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice.Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.Personalized medicine for HLA-associated drug-hypersensitivity reactions Response 2 to pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: a critical appraisal

P2860

Q26779078-643960FA-D02C-4CAC-A248-232359EAE9E0 Q26824391-E22E3CEF-487E-454B-AF29-5348595BF3D0 Q27030788-7FC5F90D-B2E8-4E0B-BAAD-BE72C597F2CC Q28547386-38E36C19-6223-4FF1-972B-269B4C574DE7 Q28660812-9E938FA9-FBA8-4F81-8799-F56A423A1F28 Q33537452-5C0C22A6-6BFD-4960-9636-659EE894B5FC Q34134390-46C264CD-CF87-4EB7-9D76-5B5F288CA1DA Q34316771-2FB41474-FD27-457C-939F-366CEE25C4A9 Q34609440-D1CE557B-F4D5-4BDC-A4C5-EA15A8376002 Q34922937-C179ECAB-2F5A-4E87-BB01-778B100D24A8 Q34976476-938E1962-D08F-45DF-BCEA-7898B9D6FEDE Q36854118-EAEB8EFA-D85E-4171-A672-3F8E258815B3 Q37510953-FBC494A1-BA5A-499C-A119-053406EED6F3 Q37605792-DAADE1B8-867F-4C35-8EA4-24337A39C1A8 Q37763930-6BBCE33A-59BC-45B7-9645-44A168ECB8C0 Q37863710-78FAE348-1E5B-4995-8FB1-27268A9B8820 Q38008438-9230F94D-5EB9-485B-BFE1-BEE124F0D357 Q38024403-88EE688F-65A4-4297-9D35-DFFB216E0153 Q38026153-C8F38D3B-11D7-46E8-A597-B1E68978B3C6 Q38033651-C9DB2317-50C7-44C9-A289-4C61CBAF28E9 Q38037649-AF62B361-AA46-4C9D-AFA5-E14D5FED4A6B Q38054629-302E43AC-54BF-4477-887D-06AB406A6527 Q38286229-30F40282-C461-49C4-B2F4-107CD93F3002 Q38454015-2EB25064-A2DF-467E-BA6F-99E8DD466011 Q38473846-31D045B5-BC7E-4E61-B135-A1204040F97A Q38886199-DB3FA81E-AB18-4865-ACF9-CF1506992368 Q42392300-7C68FDFB-323F-49D6-91E3-E690E731CD7B Q42718095-A9E91BA7-0905-446B-8F86-81193501EA8F Q44309626-1CC14E4C-F353-4725-A17D-C2875D25313B Q51245240-1EEA35B5-F8F8-49AF-A6F2-2F1A66F88860 Q53497512-0914435A-0092-40B4-A539-2AEFEF301B25 Q54206970-BF176C18-8CE9-4D4C-A8EB-8878DE4A5A6A Q57223243-0AABE0FD-9535-4215-AA38-C9021F999AED Q57302677-35ED9DF7-ED8A-4182-B0E9-7C33CF1FCC9A

P2860

Activation of T cells by carbamazepine and carbamazepine metabolites.

http://www.wikidata.org/entity/Q34543711

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Activation of T cells by carbamazepine and carbamazepine metabolites.

@ast

Activation of T cells by carbamazepine and carbamazepine metabolites.

@en

Activation of T cells by carbamazepine and carbamazepine metabolites.

@nl

type

label

Activation of T cells by carbamazepine and carbamazepine metabolites.

@ast

Activation of T cells by carbamazepine and carbamazepine metabolites.

@en

Activation of T cells by carbamazepine and carbamazepine metabolites.

@nl

prefLabel

Activation of T cells by carbamazepine and carbamazepine metabolites.

@ast

Activation of T cells by carbamazepine and carbamazepine metabolites.

@en

Activation of T cells by carbamazepine and carbamazepine metabolites.

@nl

P1433

Q34543711-E872A0E2-123D-436D-AA21-D8EB05282770

P1476

Q34543711-0E96BCB2-D480-41DE-9CAE-BEF50A73C161

P2093

Q34543711-23FA3A25-E15C-4C0B-8C2D-3E9D1C163FE4

Q34543711-38FABFF6-4061-4C35-BDB3-05A7F1ADE167

Q34543711-715FBE6E-2419-4D9B-A7D4-6F3DC8CABACE

Q34543711-90EBFE91-5B8D-4223-8916-B7CC27FED86D

Q34543711-9BD3D0E7-C962-465A-AB88-97B35EFC2ECE

Q34543711-A9D2AD0B-89CF-4674-A2CD-7BD5EF7EBE31

Q34543711-E7DDFF72-F513-4CC2-BFDA-2FF8B55044A0

Q34543711-F9987743-4BAA-4C92-AF64-77AABD5CF872

P304

Q34543711-DECA0E6A-693E-4E77-BB02-4A773E6E1362

P31

Q34543711-B2389C42-25FC-40EE-B0EC-600E38A94605

P356

Q34543711-BEE82CFB-1671-44DA-9FBB-C62B3CB2AEB2

P407

Q34543711-6927D0FB-7671-47FA-BE1C-29D4D8625936

P433

Q34543711-64124554-FC26-46E9-A5E1-186702363891

P478

Q34543711-0C254631-10E6-47D5-AEB5-36B64D5B6D44

P50

Q34543711-192B7545-D2B7-4805-8F26-D73973B1D799

Q34543711-86A84559-9C06-44C8-BD6B-727883146FAC

Q34543711-ABCD45F1-EA32-4FE5-ABB3-0C2CBACC7E24

Q34543711-B3C5975C-9261-497A-BB73-D6C94DD6A90C

Q34543711-B5CFBE4A-8946-491A-B01F-DC712185A453

P577

Q34543711-0DEDCADC-532A-40BD-97DA-678FFBFD0A1A

P698

Q34543711-5D187310-5551-47B1-B4F5-032C029E02DE

P356

J.JACI.2006.03.005

P1433

The Journal of Allergy and Clinical Immunology

P1476

Activation of T cells by carbamazepine and carbamazepine metabolites.

@en

P2093

Andrew V Stachulski

http://www.w3.org/2001/XMLSchema#string

Anita Hanson

http://www.w3.org/2001/XMLSchema#string

B Kevin Park

http://www.w3.org/2001/XMLSchema#string

Dean J Naisbitt

http://www.w3.org/2001/XMLSchema#string

Elizabeth Bowkett

http://www.w3.org/2001/XMLSchema#string

Nicola S Drummond

http://www.w3.org/2001/XMLSchema#string

Stephen E Clarke

http://www.w3.org/2001/XMLSchema#string

Ying Wu

http://www.w3.org/2001/XMLSchema#string

P304

233-241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2006.03.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Munir Pirmohamed

Werner J. Pichler

Joseph P Sanderson

P577

2006-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16815161

http://www.w3.org/2001/XMLSchema#string